These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
645 related articles for article (PubMed ID: 31643109)
1. Structurally distinct α-synuclein fibrils induce robust parkinsonian pathology. Hayakawa H; Nakatani R; Ikenaka K; Aguirre C; Choong CJ; Tsuda H; Nagano S; Koike M; Ikeuchi T; Hasegawa M; Papa SM; Nagai Y; Mochizuki H; Baba K Mov Disord; 2020 Feb; 35(2):256-267. PubMed ID: 31643109 [TBL] [Abstract][Full Text] [Related]
2. The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of α-synuclein, and enhances its secretion and nuclear localization in cells. Fares MB; Ait-Bouziad N; Dikiy I; Mbefo MK; Jovičić A; Kiely A; Holton JL; Lee SJ; Gitler AD; Eliezer D; Lashuel HA Hum Mol Genet; 2014 Sep; 23(17):4491-509. PubMed ID: 24728187 [TBL] [Abstract][Full Text] [Related]
3. Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains. Longhena F; Faustini G; Varanita T; Zaltieri M; Porrini V; Tessari I; Poliani PL; Missale C; Borroni B; Padovani A; Bubacco L; Pizzi M; Spano P; Bellucci A Brain Pathol; 2018 Nov; 28(6):875-888. PubMed ID: 29330884 [TBL] [Abstract][Full Text] [Related]
4. Progression of phosphorylated α-synuclein in Macaca fuscata. Kawakami I; Motoda A; Hashimoto M; Shimozawa A; Masuda-Suzukake M; Ohtani R; Takase M; Kumashiro M; Samejima K; Hasegawa M Brain Pathol; 2021 Sep; 31(5):e12952. PubMed ID: 33754430 [TBL] [Abstract][Full Text] [Related]
5. Physicochemical characterization of the G51D mutation of α-synuclein that is responsible for its severe cytotoxicity. Murata T; Tochio N; Utsunomiya-Tate N Neurosci Lett; 2021 Aug; 760():136077. PubMed ID: 34161822 [TBL] [Abstract][Full Text] [Related]
6. Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson's disease. Faustini G; Longhena F; Varanita T; Bubacco L; Pizzi M; Missale C; Benfenati F; Björklund A; Spano P; Bellucci A Acta Neuropathol; 2018 Oct; 136(4):621-639. PubMed ID: 30046897 [TBL] [Abstract][Full Text] [Related]
7. Oligodendrocytes Prune Axons Containing α-Synuclein Aggregates In Vivo: Lewy Neurites as Precursors of Glial Cytoplasmic Inclusions in Multiple System Atrophy? De Nuccio F; Kashyrina M; Serinelli F; Laferrière F; Lofrumento DD; De Giorgi F; Ichas F Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830639 [TBL] [Abstract][Full Text] [Related]
14. Modeling Parkinson's disease pathology by combination of fibril seeds and α-synuclein overexpression in the rat brain. Thakur P; Breger LS; Lundblad M; Wan OW; Mattsson B; Luk KC; Lee VMY; Trojanowski JQ; Björklund A Proc Natl Acad Sci U S A; 2017 Sep; 114(39):E8284-E8293. PubMed ID: 28900002 [TBL] [Abstract][Full Text] [Related]
15. α-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Peelaerts W; Bousset L; Van der Perren A; Moskalyuk A; Pulizzi R; Giugliano M; Van den Haute C; Melki R; Baekelandt V Nature; 2015 Jun; 522(7556):340-4. PubMed ID: 26061766 [TBL] [Abstract][Full Text] [Related]
16. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease. Lo Bianco C; Ridet JL; Schneider BL; Deglon N; Aebischer P Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10813-8. PubMed ID: 12122208 [TBL] [Abstract][Full Text] [Related]
17. Neuroinflammation and α-synuclein dysfunction potentiate each other, driving chronic progression of neurodegeneration in a mouse model of Parkinson's disease. Gao HM; Zhang F; Zhou H; Kam W; Wilson B; Hong JS Environ Health Perspect; 2011 Jun; 119(6):807-14. PubMed ID: 21245015 [TBL] [Abstract][Full Text] [Related]
19. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid. Conway KA; Harper JD; Lansbury PT Biochemistry; 2000 Mar; 39(10):2552-63. PubMed ID: 10704204 [TBL] [Abstract][Full Text] [Related]